IRF4 haploinsufficiency in a family with Whipple's disease
- INSERM U1163, France
- Sidra Medical and Research Center, Qatar
- The Rockefeller University, United States
- University Aix-Marseille (URMITE), France
- Garvan Institute of Medical Research, Australia
- Memorial Sloan Kettering Cancer Center, United States
- Institut Pasteur, France
- Cochin Hospital, France
- Imagine Institute, Paris Descartes University, France
Abstract
Most humans are exposed to Tropheryma whipplei (Tw). Whipple's disease (WD) strikes only a small minority of individuals infected with Tw (<0.01%), whereas asymptomatic chronic carriage is more common (<25%). We studied a multiplex kindred, containing four WD patients and five healthy Tw chronic carriers. We hypothesized that WD displays autosomal dominant (AD) inheritance, with age-dependent incomplete penetrance. We identified a single very rare non-synonymous mutation in the four patients: the private R98W variant of IRF4, a transcription factor involved in immunity. The five Tw carriers were younger, and also heterozygous for R98W. We found that R98W was loss-of-function, modified the transcriptome of heterozygous leukocytes following Tw stimulation, and was not dominant-negative. We also found that only six of the other 153 known non-synonymous IRF4 variants were loss-of-function. Finally, we found that IRF4 had evolved under purifying selection. AD IRF4 deficiency can underlie WD by haploinsufficiency, with age-dependent incomplete penetrance.
Data availability
-
IRF4 haplo-insufficiency underlies a familial form of Whipple's diseasePublicly available at the NCBI Gene Expression Omnibus (accession no: GSE102862).
Article and author information
Author details
Jean-Laurent Casanova
Funding
Centre National de la Recherche Scientifique
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0008-02)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-14-CE14-0007-02)
- Lluis Quintana-Murci
H2020 European Research Council
- Lluis Quintana-Murci
National Health and Medical Research Council (1113904)
- Stuart G Tangye
University of New South Wales
- Lisa Worley
- Tina Nguyen
Agence Nationale de la Recherche (ANR-16-CE17-0005-01)
- Antoine Guérin
National Institutes of Health (5R01AI089970-02)
- Jean-Laurent Casanova
National Health and Medical Research Council (1042925)
- Cindy S Ma
Office of Health and Medical Research
- Cindy S Ma
- Stuart G Tangye
H2020 European Research Council (281297)
- Lluis Quintana-Murci
- Jean-Laurent Casanova
Seventh Framework Programme (FP/2007-2013)
- Lluis Quintana-Murci
Agence Nationale de la Recherche (ANR-IFNPHOX (ANR-13-ISV3-001-01))
- Jacinta Bustamante
Agence Nationale de la Recherche (ANR-10-LABX-62-IBEID)
- Lluis Quintana-Murci
- Laurent Abel
- Jean-Laurent Casanova
Agence Nationale de la Recherche (ANR-GENMSMD (ANR-16-CE17-0005-01))
- Jacinta Bustamante
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: Informed consent was obtained from all family members, and the study was approved by the national ethics committee.
Copyright
© 2018, Guérin et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,990
- views
-
- 509
- downloads
-
- 48
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
IRF4 haploinsufficiency in a family with Whipple's disease
eLife 7:e32340.
https://doi.org/10.7554/eLife.32340
Further reading
-
- Immunology and Inflammation
Chronic antigenic stimulation can trigger the formation of interleukin 10 (IL-10)-producing T-regulatory type 1 (TR1) cells in vivo. We have recently shown that murine T-follicular helper (TFH) cells are precursors of TR1 cells and that the TFH-to-TR1 cell transdifferentiation process is characterized by the progressive loss and acquisition of opposing transcription factor gene expression programs that evolve through at least one transitional cell stage. Here, we use a broad range of bulk and single-cell transcriptional and epigenetic tools to investigate the epigenetic underpinnings of this process. At the single-cell level, the TFH-to-TR1 cell transition is accompanied by both, downregulation of TFH cell-specific gene expression due to loss of chromatin accessibility, and upregulation of TR1 cell-specific genes linked to chromatin regions that remain accessible throughout the transdifferentiation process, with minimal generation of new open chromatin regions. By interrogating the epigenetic status of accessible TR1 genes on purified TFH and conventional T-cells, we find that most of these genes, including Il10, are already poised for expression at the TFH cell stage. Whereas these genes are closed and hypermethylated in Tconv cells, they are accessible, hypomethylated, and enriched for H3K27ac-marked and hypomethylated active enhancers in TFH cells. These enhancers are enriched for binding sites for the TFH and TR1-associated transcription factors TOX-2, IRF4, and c-MAF. Together, these data suggest that the TR1 gene expression program is genetically imprinted at the TFH cell stage.
-
- Genetics and Genomics
- Immunology and Inflammation
Systemic lupus erythematosus (SLE) is an autoimmune disease, the pathophysiology and genetic basis of which are incompletely understood. Using a forward genetic screen in multiplex families with SLE, we identified an association between SLE and compound heterozygous deleterious variants in the non-receptor tyrosine kinases (NRTKs) ACK1 and BRK. Experimental blockade of ACK1 or BRK increased circulating autoantibodies in vivo in mice and exacerbated glomerular IgG deposits in an SLE mouse model. Mechanistically, NRTKs regulate activation, migration, and proliferation of immune cells. We found that the patients’ ACK1 and BRK variants impair efferocytosis, the MERTK-mediated anti-inflammatory response to apoptotic cells, in human induced pluripotent stem cell (hiPSC)-derived macrophages, which may contribute to SLE pathogenesis. Overall, our data suggest that ACK1 and BRK deficiencies are associated with human SLE and impair efferocytosis in macrophages.
